Novel transcript, antisense to A-kinase anchoring protein 6 (ENSG00000293859)

ENSG00000293859, described as a "novel transcript, antisense to AKAP6," is a non-coding RNA transcript that is transcribed from the DNA strand opposite to the A-kinase anchoring protein 6 (AKAP6) gene[1]. This antisense transcript does not code for a protein but may exert regulatory effects on the sense (coding) AKAP6 gene via mechanisms common to natural antisense transcripts (NATs), including transcriptional interference, RNA masking, or RNA duplex formation[2][3][4]. Such antisense transcripts can influence gene expression dynamics, alternative splicing, and chromatin state of their overlapping or neighboring protein-coding genes. There are no established therapeutic drugs targeting this transcript, nor is it considered a druggable receptor, enzyme, or direct disease marker at this time. Its primary classification is as a non-coding regulatory RNA rather than a classical therapeutic target. This entry likely represents an RNA annotation rather than a canonical drug target, such as a receptor or enzyme[1]. If used as a target in a therapeutic context, more experimental validation would be needed. Some databases may only provide basic annotation information for such transcripts, not functional or phenotypic data. The designation "antisense to AKAP6" indicates potential regulatory crosstalk with the AKAP6 gene, which could impact cellular signaling via AKAP6 but does not itself represent a classical therapeutic target[2][3][4].

Other names

Novel transcript, antisense to AKAP6

Transcriptional interference, RNA masking, double-stranded RNA-dependent gene regulation, chromatin modulation[2][3][4]